HPV vaccine cuts future disease risk for women diagnosed with pre-cancers.
Women diagnosed with pre-cancerous cervical conditions after receiving the human papilloma virus vaccine can still benefit from a considerably reduced risk of further virus-related disease, suggests a global study.